Jul 24, 2024 | and Marketplace Modernization Act (CREAMMA) | Cannabis | Cannabis Regulatory | cannabis rescheduling | DEA | Department of Justice | Enforcement Assistance | Federal Government | Marijuana | medical benefits | Proposed Rule | Rescheduling | Schedule I | Schedule III | therapeutic | Division of Law | Press Release | Statutes, Regulations & Rules
Attorney General Matthew J. Platkin submitted a comment letter on Monday to the federal Drug Enforcement Administration (DEA) supporting the DEA’s proposed rule that would reschedule marijuana under the Controlled Substances Act, from Schedule I, which is reserved for highly addictive and dangerous substances like heroin, to Schedule III, in recognition of marijuana’s potential for therapeutic and medical benefits and lower risk for abuse.
Jun 15, 2021 | Cannabis | Consumer Fraud | deception | Marijuana | misrepresentation | Division of Consumer Affairs | Press Release
Warnings Are Latest Actions to Protect Integrity of New Jersey’s Regulated Cannabis Markets For Immediate Release: June 15, 2021 Office of The Attorney General- Gurbir S. Grewal, Attorney GeneralDivision of Consumer Affairs- Kaitlin A. Caruso, Acting Director For...
